DGS Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.69M Buy
14,018
+2,118
+18% +$245K 0.28% 72
2025
Q4
$1.25M Sell
11,900
-623
-5% -$58.5K 0.21% 91
2025
Q3
$1.05M Sell
12,523
-1,173
-9% -$96.6K 0.19% 104
2025
Q2
$1.08M Sell
13,696
-1,996
-13% -$159K 0.22% 81
2025
Q1
$1.41M Buy
15,692
+4,119
+36% +$385K 0.37% 48
2024
Q4
$1.15M Sell
11,573
-1,918
-14% -$198K 0.29% 57
2024
Q3
$1.53M Buy
13,491
+718
+6% +$85.3K 0.42% 41
2024
Q2
$1.58M Buy
12,773
+2,652
+26% +$342K 0.44% 33
2024
Q1
$1.34M Buy
10,121
+4,218
+71% +$520K 0.38% 37
2023
Q4
$644K Sell
5,903
-573
-9% -$59.5K 0.25% 78
2023
Q3
$667K Sell
6,476
-145
-2% -$15.6K 0.33% 65
2023
Q2
$764K Buy
6,621
+480
+8% +$54.5K 0.38% 54
2023
Q1
$653K Buy
6,141
+7
+0.1% +$756 0.36% 59
2022
Q4
$681K Buy
6,134
+530
+9% +$54.2K 0.45% 47
2022
Q3
$483K Buy
5,604
+788
+16% +$70.3K 0.32% 60
2022
Q2
$439K Buy
4,816
+1,322
+38% +$117K 0.35% 60
2022
Q1
$287K Buy
3,494
+528
+18% +$41.6K 0.18% 126
2021
Q4
$227K Buy
+2,966
New +$236K 0.14% 138

Other funds holding MRK

DGS Capital Management's MRK Position: Q1 2026 in Review

DGS Capital Management increased its Merck (MRK) stake by 18% in Q1 2026, buying an estimated $245K and bringing the position to 14,018 shares worth $1.69M. The position accounts for 0.28% of the portfolio, ranked #72.

DGS Capital Management first reported a position in MRK in Q4 2021 and has held it in 18 quarters since. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • DGS Capital Management held 14,018 shares of Merck worth $1.69M as of Q1 2026.
  • DGS Capital Management bought 2,118 Merck shares in Q1 2026, an estimated $245K.
  • Merck made up 0.28% of DGS Capital Management's portfolio in Q1 2026, its #72 holding.
  • DGS Capital Management first reported a position in Merck in Q4 2021 and has held it in 18 quarters since.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on DGS Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.